Kura Oncology Stock Forecast

Hold candidate since Aug 10, 2026

The Kura Oncology stock price gained 2.93% on the last trading day (Monday, 10th Aug 2026), rising from $9.57 to $9.85. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.64% from a day low at $9.48 to a day high of $9.92. The price has risen in 6 of the last 10 days but is still down by -2.96% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 582 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $12.99 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.64% during the next 3 months and, with a 90% probability hold a price between $9.52 and $13.06 at the end of this 3-month period.

KURA Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 10.30%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kura Oncology stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $10.47. On a fall, the stock will find some support from the short-term average at $9.37. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Kura Oncology stock

On the downside, the stock finds support just below today's level from accumulated volume at $9.31 and $8.97. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Kura Oncology finds support just below today's level at $9.31. If this is broken, then the next support from accumulated volume will be at $8.97 and $8.74.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.440 between high and low, or 4.64%. For the last week, the stock has had daily average volatility of 4.19%.

Our recommended stop-loss: $9.43 (-4.26%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (KURA) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Kura Oncology to open at $9.75, and during the day (based on 14 day Average True Range), to move between $9.60 and $10.10, which gives a possible trading interval of +/-$0.496 (+/-5.17%) up or down from last closing price. If Kura Oncology takes out the full calculated possible swing range there will be an estimated 5.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $10.34 (4.97%) than the support at $9.31 (5.48%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Kura Oncology stock A Buy?

Kura Oncology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.125 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $9.75 ( 1.02%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk